Status:
COMPLETED
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Lead Sponsor:
Dalhousie University
Collaborating Sponsors:
Public Health Agency of Canada (PHAC)
Canadian Institutes of Health Research (CIHR)
Conditions:
Influenza
Eligibility:
All Genders
16+ years
Brief Summary
This surveillance study will include all consenting adults hospitalized with influenza (cases) at the SOS network of hospitals as well as influenza negative patients(controls), to assess vaccine effec...
Detailed Description
The Canadian Immunization Research Network(CIRN) is a collaborative research network which brings together over 100 investigators in over 40 institutions to evaluate all factors relevant to the introd...
Eligibility Criteria
Inclusion
- Adult patients ≥ 16 years of age admitted to participating SOS Network hospitals with the following admitting diagnoses will be eligible for screening:
- pneumonia
- acute exacerbation of chronic obstructive pulmonary disease (AECOPD) or asthma
- unexplained sepsis
- Any other respiratory infection or diagnosis Or any respiratory or influenza-like symptom )(eg dyspnea, cough, sore throat, myalgia, arthralgia, fever, delirium/altered level of consciousness, CHF)
Exclusion
- Patients whose reason for admission was clearly unrelated to the presence of influenza (for example, patients admitted due to trauma, elective surgery, or patients who have an alternative diagnosis that is clearly not respiratory,, e.g. cellulitis, intra-abdominal process, or gastrointestinal bleeding) Unless being enrolled as a nosocomial influenza case
- Patients whose onset of symptoms was prior to or within 72 hours of hospital admission but who were not tested for influenza within 7 days of hospital admission. These should be captured on the screening form as screen failures.
- No children in care will be enrolled in the study
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
4197 Patients enrolled
Trial Details
Trial ID
NCT01517191
Start Date
November 1 2011
End Date
December 1 2016
Last Update
March 30 2018
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General
Vancouver, British Columbia, Canada
2
The Moncton Hospital
Moncton, New Brunswick, Canada, E1C 6Z8
3
Saint John Regional Hospital
Saint John, New Brunswick, Canada
4
QEII Health Science Centre
Halifax, Nova Scotia, Canada, B3K 6R8